BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19878274)

  • 21. New antifungal drugs and the pediatric cancer patient: current status of clinical development.
    Groll AH; Lehrnbecher T
    Klin Padiatr; 2005; 217(3):158-68. PubMed ID: 15858708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Voriconazole-micafungin combination therapy for acute lymphoblastic leukemia.
    Okamoto T; Koh K; Takita J; Furuya A; Kato M; Ida K
    Pediatr Int; 2010 Feb; 52(1):137-41. PubMed ID: 20158658
    [No Abstract]   [Full Text] [Related]  

  • 23. Caspofungin versus liposomal amphotericin B for empirical therapy.
    Danaher PJ
    N Engl J Med; 2005 Jan; 352(4):410-4; author reply 410-4. PubMed ID: 15675092
    [No Abstract]   [Full Text] [Related]  

  • 24. Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study.
    Riedel A; Choe L; Inciardi J; Yuen C; Martin T; Guglielmo BJ
    BMC Infect Dis; 2007 Jul; 7():70. PubMed ID: 17605773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New development in the treatment of deep-seated mycoses].
    Maesaki S
    Nihon Naika Gakkai Zasshi; 2007 Sep; 96(9):1993-8. PubMed ID: 17929445
    [No Abstract]   [Full Text] [Related]  

  • 26. Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease.
    Verma A; Williams S; Trifilio S; Zembower T; Mehta J
    Bone Marrow Transplant; 2004 May; 33(10):1065-6. PubMed ID: 15048146
    [No Abstract]   [Full Text] [Related]  

  • 27. Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
    Ullmann AJ; Heussel CP; Cornely OA
    N Engl J Med; 2002 May; 346(22):1745-7; author reply 1745-7. PubMed ID: 12041526
    [No Abstract]   [Full Text] [Related]  

  • 28. Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
    Johnson JR
    N Engl J Med; 2002 May; 346(22):1745-7; author reply 1745-7. PubMed ID: 12037157
    [No Abstract]   [Full Text] [Related]  

  • 29. Combined therapy in treatment of murine infection by Fusarium solani.
    Ruíz-Cendoya M; Mariné M; Guarro J
    J Antimicrob Chemother; 2008 Sep; 62(3):543-6. PubMed ID: 18495651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternaria sinusitis in children with acute myeloid leukemia: case reports from the Childhood Acute Myeloid Leukemia Infection Research Group.
    Maloney AM; Ethier MC; Mitchell D; Zaoutis T; Sung L;
    Leuk Lymphoma; 2010 Feb; 51(2):345-7. PubMed ID: 20001237
    [No Abstract]   [Full Text] [Related]  

  • 31. [Update on therapy of invasive mycoses in hematology and oncology].
    Maschmeyer G; Haas A; Böhme A
    Dtsch Med Wochenschr; 2005 Jun; 130(22):1381-4. PubMed ID: 15915381
    [No Abstract]   [Full Text] [Related]  

  • 32. Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia.
    Rieger C; Geiger S; Herold T; Nickenig C; Ostermann H
    Eur J Clin Microbiol Infect Dis; 2007 Nov; 26(11):843-5. PubMed ID: 17690928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation.
    Mattei D; Mordini N; Lo Nigro C; Ghirardo D; Ferrua MT; Osenda M; Gallamini A; Bacigalupo A; Viscoli C
    Bone Marrow Transplant; 2002 Dec; 30(12):967-70. PubMed ID: 12476292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections.
    Yilmaz D; Balkan C; Ay Y; Akin M; Karapinar B; Kavakli K
    Mycoses; 2011 May; 54(3):234-42. PubMed ID: 19906090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole.
    Paul S; Marty FM; Colson YL
    Ann Thorac Surg; 2006 Jul; 82(1):338-40. PubMed ID: 16798251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decisions about voriconazole versus liposomal amphotericin B.
    Walsh TJ; Lee J; Dismukes WE
    N Engl J Med; 2002 May; 346(19):1499; author reply 1499. PubMed ID: 12000825
    [No Abstract]   [Full Text] [Related]  

  • 37. Voriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis.
    Chamilos G; Kontoyiannis DP
    J Infect; 2005 Nov; 51(4):e225-8. PubMed ID: 16291275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Voriconazole versus liposomal amphotericin B in patients with neutropenia and persistent fever.
    Powers JH; Dixon CA; Goldberger MJ
    N Engl J Med; 2002 Jan; 346(4):289-90. PubMed ID: 11807157
    [No Abstract]   [Full Text] [Related]  

  • 39. [Current indications for voriconazole in onco-hematological patients].
    Jarque I; Sanz MA
    Rev Iberoam Micol; 2007 Sep; 24(3):213-6. PubMed ID: 17874858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants.
    Marty FM; Cosimi LA; Baden LR
    N Engl J Med; 2004 Feb; 350(9):950-2. PubMed ID: 14985500
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.